Molecular pathway activation-based analysis for personalized prescription of tyr
- This topic has 0 replies, 1 voice, and was last updated 4 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Molecular pathway activation-based analysis for personalized prescription of tyrosine kinase inhibitors for advanced solid tumor patients.
http://abstracts.asco.org/239/AbstView_239_262869.html
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.